Researchers Afraid to Publish Vaccine Heart Inflammation Study & Risk Funding Loss from Big Pharma

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).

To receive Global Research’s Daily Newsletter (selected articles), click here.

Visit and follow us on Instagram at @crg_globalresearch.

***

On Nov. 8, 2021, an abstract appeared in the Journal Circulation of the American Heart Association (AMA) showing that COVID vaccines “dramatically” increase heart inflammation in the people that were studies. Plus led to a substantial increase in the risk of heart complications, like myocarditis and heart attacks.

Twitter put a note on the post by the AMA, stating that it could be misleading and the study could have errors in it.

Cardiologist and NHS consultant Dr. Aseem Malhotra appeared on GBN explaining the findings, and while he was doing so he mentioned another study conducted by a well known cardiologist, who wished to remain anonymous, that found the same thing.

He stated the following,

“A few days ago after this was published (the abstract), somebody from a very prestigious British institution, cardiologist department, a researcher. A whistleblower if you’d like contacted me to say that the researchers in this department had found something similar within the coronary arteries linked to the vaccine, inflammation from imaging studies around the coronary arteries.

And they had a meeting, and these researchers at the moment have decided that they’re not going to publish their findings. Because they are concerned about losing research money from the drug industry.

Now this person was very upset about it, and um, I obviously wanted to share this on GB news today.”

-Dr. Aseem Malhotra

What does this say about the current moment our world is living in? Important information is concealed due to the fact it may threaten one’s ability to work, leaving the public uninformed. Pharmaceutical companies not only threaten to stop ones funding if findings go against their business interests, but they also refuse acknowledge science that calls their products into question.

Many of these companies have long had a disregard for ethics and morals. They’ve even gone so far as to lie about the efficacy and the safety of their products. Robert G. Evans, PhD, Emeritus Professor, Vancouver School of Economics, UBC wrote a paper in 2010 titled “Tough on Crime? Pfizer and the CIHR,” it is accessible through the National Library of Medicine (PubMed). In it he outlines how Pfizer has been a “habitual offender,” constantly engaging in illegal and criminal activities. This particular paper points out that from 2002 to 2010, Pfizer has been “assessed $3 billion in criminal convictions, civil penalties and jury awards” and has set records for both criminal fines and total penalties. Keep in mind we are now in 2021 and these numbers have likely risen.

This is concerning, especially given the fact that these companies have big control over academic and medical institutions, as well as medical education.

“The medical profession is being bought by the pharmaceutical industry, not only in terms of the practice of medicine, but also in terms of teaching and research. The academic institutions of this country are allowing themselves to be the paid agents of the pharmaceutical industry. I think it’s disgraceful.”  

– Arnold Seymour Relman (1923-2014), Harvard Professor of Medicine and Former Editor-in-Chief of the New England Medical Journal

*

Note to readers: Please click the share buttons above or below. Follow us on Instagram, @crg_globalresearch. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Featured image: Dr. Aseem Malhotra. GBN News.


Articles by: Arjun Walia

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]